MedTrace Logo

Study of Arm and Putter Movement in Golfers With Golfer's Cramp

NCT02032758 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2016-07-25

Study results available
· View outcomes & findings →

Summary

The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.

Conditions

  • Occupational; Cramp(s)

Interventions

DRUG

Propranolol

Single oral dose of 10 mg propranolol

DEVICE

Opal Device

The Opal Device (APDM, Inc.) will be used to measure wrist movement.

PROCEDURE

Science and Motion PuttLab (SAM)

The SAM will be used to study putter stroke movement and ball movement.

DEVICE

Surface Electromyography EMG

The surface EMG will be used to evaluate co-contraction of the wrist flexor/extensor muscle groups and the wrist pronator/supinator muscle groups.

Sponsors & Collaborators

Principal Investigators

  • Charles Adler, MD, PhD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032758 on ClinicalTrials.gov